Influence
April 10, 2020

Returning to normal in the post-pandemic world

Covid-19 is omnipresent. But what happens after conditions begin to improve? Regenstrief President and CEO Peter Embí, M.D., and VP for Data and Analytics Shaun Grannis, M.D., propose strategies for responsibly getting to the new normal of the post-pandemic world.

Their essay, “Here’s what to consider when reopening the economy“, an Indianapolis Business Journal (IBJ) Forefront column, was published April 10, 2020.

“Beating this pandemic will take time,” they write. “It will not be easy, but we can and will succeed. Unfortunately, there are no short-cuts, only tempting detours that risk prolonging this painful journey. To arrive safely, we will need good data-driven decision making, continued collaboration, and steadfast determination.”

The two clinician-researchers call for data-driven development of a rational plan for gradual easing of social-distancing, sheltering at home, and temporary closure of nonessential businesses (collectively called “nonpharmaceutical interventions”) as communities begin the slow return to a healthy and prosperous life.

They highlight five areas critical for consideration as the state and nation move toward terminating personal isolation and business closure mandates, hopefully in the not-too-distant future. These are: (1) designation of principles for winding down these nonpharmaceutical interventions; (2) tracking and testing of the virus, as well as maintaining an early-warning system to detect new outbreaks; (3) gaining a more nuanced understanding of the disease; (4) treatment and vaccine development through expansion of clinical trials; (5) learning from the experiences of other nations.

Overcoming this pandemic will take time and not be easy, but Dr. Embí and Dr. Grannis observe that success will require good data-driven decision-making along with continued collaboration and steadfast determination.

Read the IBJ Forefront column.

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight